<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Euthymics Bioscience</title>
	<atom:link href="http://euthymics.com/feed/" rel="self" type="application/rss+xml" />
	<link>http://euthymics.com</link>
	<description>A Neuroscience-Focused, Clinical Stage Company</description>
	<lastBuildDate>Thu, 16 Feb 2012 18:16:58 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.1</generator>
		<item>
		<title>Clinical investigator Dr. Ronald Fuchs discusses TRIADE and amitifadine on Philadelphia’s 6 ABC</title>
		<link>http://euthymics.com/in-the-news/clinical-investigator-dr-ronald-fuchs-discusses-triade-and-amitifadine-on-philadelphia%e2%80%99s-6-abc/</link>
		<comments>http://euthymics.com/in-the-news/clinical-investigator-dr-ronald-fuchs-discusses-triade-and-amitifadine-on-philadelphia%e2%80%99s-6-abc/#comments</comments>
		<pubDate>Wed, 15 Feb 2012 18:14:55 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[In The News]]></category>

		<guid isPermaLink="false">http://euthymics.com/?p=446</guid>
		<description><![CDATA[February 15, 2012 &#8211; Clinical investigator Dr. Ronald Fuchs discusses TRIADE and amitifadine on Philadelphia’s &#8230; <a href="http://euthymics.com/in-the-news/clinical-investigator-dr-ronald-fuchs-discusses-triade-and-amitifadine-on-philadelphia%e2%80%99s-6-abc/"> </a>]]></description>
			<content:encoded><![CDATA[<p>February 15, 2012 &#8211; <a href="http://abclocal.go.com/wpvi/story?section=news/health&#038;id=8545273">Clinical investigator Dr. Ronald Fuchs discusses TRIADE and amitifadine on Philadelphia’s 6 ABC</a></p>
]]></content:encoded>
			<wfw:commentRss>http://euthymics.com/in-the-news/clinical-investigator-dr-ronald-fuchs-discusses-triade-and-amitifadine-on-philadelphia%e2%80%99s-6-abc/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>TRIADE clinical investigator Dr. Riaz Baber discusses the trial and amitifadine in the Naperville Sun</title>
		<link>http://euthymics.com/in-the-news/triade-clinical-investigator-dr-riaz-baber-discusses-the-trial-and-amitifadine-in-the-naperville-sun/</link>
		<comments>http://euthymics.com/in-the-news/triade-clinical-investigator-dr-riaz-baber-discusses-the-trial-and-amitifadine-in-the-naperville-sun/#comments</comments>
		<pubDate>Tue, 07 Feb 2012 18:29:01 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[In The News]]></category>

		<guid isPermaLink="false">http://euthymics.com/?p=434</guid>
		<description><![CDATA[February 7th, 2012 &#8211; Click here to view]]></description>
			<content:encoded><![CDATA[<p>February 7th, 2012 &#8211; <a href="http://napervillesun.suntimes.com/lifestyles/10371001-423/valentines-day-no-holiday-for-depressed.html">Click here to view</a></p>
]]></content:encoded>
			<wfw:commentRss>http://euthymics.com/in-the-news/triade-clinical-investigator-dr-riaz-baber-discusses-the-trial-and-amitifadine-in-the-naperville-sun/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Dr. Michael Downing, TRIADE clinical investigator, discusses depression and amitifadine on Dallas’ DFW Closeup</title>
		<link>http://euthymics.com/in-the-news/dr-michael-downing-triade-clinical-investigator-discusses-depression-and-amitifadine-on-dallas%e2%80%99-dfw-closeup/</link>
		<comments>http://euthymics.com/in-the-news/dr-michael-downing-triade-clinical-investigator-discusses-depression-and-amitifadine-on-dallas%e2%80%99-dfw-closeup/#comments</comments>
		<pubDate>Sun, 15 Jan 2012 18:14:19 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[In The News]]></category>

		<guid isPermaLink="false">http://euthymics.com/?p=426</guid>
		<description><![CDATA[January 15, 2012 – Click here to view]]></description>
			<content:encoded><![CDATA[<p>January 15, 2012 – <a href="http://www.the33tv.com/videogallery/67332068/Community/1/15/12-Clinical-Depression-Trial#pl-62805430">Click here to view</a></p>
]]></content:encoded>
			<wfw:commentRss>http://euthymics.com/in-the-news/dr-michael-downing-triade-clinical-investigator-discusses-depression-and-amitifadine-on-dallas%e2%80%99-dfw-closeup/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>TRIADE investigator Dr. Eugene DuBoff discusses depression and Euthymics’ amitifadine in The Denver Post</title>
		<link>http://euthymics.com/in-the-news/triade-investigator-dr-eugene-duboff-discusses-depression-and-euthymics%e2%80%99-amitifadine-in-the-denver-post/</link>
		<comments>http://euthymics.com/in-the-news/triade-investigator-dr-eugene-duboff-discusses-depression-and-euthymics%e2%80%99-amitifadine-in-the-denver-post/#comments</comments>
		<pubDate>Tue, 13 Dec 2011 22:13:20 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[In The News]]></category>

		<guid isPermaLink="false">http://euthymics.com/?p=421</guid>
		<description><![CDATA[December 12, 2011 - Click here to view &#160;]]></description>
			<content:encoded><![CDATA[<p>December 12, 2011 - <a href="http://www.denverpost.com/search/ci_19526035 " target="_blank">Click here to view</a></p>
<p>&nbsp;</p>
]]></content:encoded>
			<wfw:commentRss>http://euthymics.com/in-the-news/triade-investigator-dr-eugene-duboff-discusses-depression-and-euthymics%e2%80%99-amitifadine-in-the-denver-post/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Euthymics Bioscience, Inc. Presents Data That Support Advancing EB-1020 Into Clinical Trials For Adult ADHD</title>
		<link>http://euthymics.com/press-releases/euthymics-bioscience-inc-presents-data-that-supports-advancing-eb-1020-into-clinical-trials-for-adult-adhd/</link>
		<comments>http://euthymics.com/press-releases/euthymics-bioscience-inc-presents-data-that-supports-advancing-eb-1020-into-clinical-trials-for-adult-adhd/#comments</comments>
		<pubDate>Wed, 07 Dec 2011 12:32:00 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Press Releases]]></category>

		<guid isPermaLink="false">http://euthymics.com/?p=382</guid>
		<description><![CDATA[Euthymics Bioscience, Inc. Presents Data That Support Advancing EB-1020 Into Clinical Trials For Adult ADHD. &#8230; <a href="http://euthymics.com/press-releases/euthymics-bioscience-inc-presents-data-that-supports-advancing-eb-1020-into-clinical-trials-for-adult-adhd/"> </a>]]></description>
			<content:encoded><![CDATA[<p>Euthymics Bioscience, Inc. Presents Data That Support Advancing EB-1020 Into Clinical Trials For Adult ADHD.</p>
<p>&nbsp;</p>
<p><a title="EB-1020_ACNP_120611_FINAL.pdf" href="http://euthymics.com/wp-content/uploads/2011/12/EB-1020_ACNP_120611_FINAL.pdf">EB-1020_ACNP_120611_FINAL.pdf</a></p>
<p>&nbsp;</p>
]]></content:encoded>
			<wfw:commentRss>http://euthymics.com/press-releases/euthymics-bioscience-inc-presents-data-that-supports-advancing-eb-1020-into-clinical-trials-for-adult-adhd/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Euthymics Featured in BioCentury Emerging Company Profile</title>
		<link>http://euthymics.com/press-releases/december-5th-euthymics-featured-in-biocentury-emerging-company-profile/</link>
		<comments>http://euthymics.com/press-releases/december-5th-euthymics-featured-in-biocentury-emerging-company-profile/#comments</comments>
		<pubDate>Mon, 05 Dec 2011 17:42:04 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[In The News]]></category>
		<category><![CDATA[Press Releases]]></category>

		<guid isPermaLink="false">http://euthymics.com/?p=391</guid>
		<description><![CDATA[December 5, 2011  - Emerging Company Profile – Euthymics: Balancing Act &#160; &#160;]]></description>
			<content:encoded><![CDATA[<p style="text-align: left;">December 5, 2011  -</p>
<p style="text-align: left;"><a title="Emerging Company Profile – Euthymics: Balancing Act" href="http://euthymics.com/wp-content/uploads/2011/12/EUTHYMICS_BIOSCIENCE_ECP_BERNSTEIN_REPORT_120511bc1.pdf" target="_blank">Emerging Company Profile – Euthymics: Balancing Act</a></p>
<p>&nbsp;</p>
<p>&nbsp;</p>
]]></content:encoded>
			<wfw:commentRss>http://euthymics.com/press-releases/december-5th-euthymics-featured-in-biocentury-emerging-company-profile/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>TRIADE clinical trial investigator Dr. Kashinath Yadalam discusses TRIADE and Euthymics’ amitifadine on Lake Charles, LA’s KPLC</title>
		<link>http://euthymics.com/in-the-news/triade-clinical-trial-investigator-dr-kashinath-yadalam-discusses-triade-and-euthymics%e2%80%99-amitifadine-on-lake-charles-la%e2%80%99s-kplc/</link>
		<comments>http://euthymics.com/in-the-news/triade-clinical-trial-investigator-dr-kashinath-yadalam-discusses-triade-and-euthymics%e2%80%99-amitifadine-on-lake-charles-la%e2%80%99s-kplc/#comments</comments>
		<pubDate>Wed, 23 Nov 2011 21:57:39 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[In The News]]></category>

		<guid isPermaLink="false">http://euthymics.com/?p=404</guid>
		<description><![CDATA[November 23, 2011 - Click here to view]]></description>
			<content:encoded><![CDATA[<p><strong>November 23, 2011 </strong>- <a href="http://www.kplctv.com/story/16109644/holiday-blues-or-clinical-depression " target="_blank">Click here to view</a></p>
]]></content:encoded>
			<wfw:commentRss>http://euthymics.com/in-the-news/triade-clinical-trial-investigator-dr-kashinath-yadalam-discusses-triade-and-euthymics%e2%80%99-amitifadine-on-lake-charles-la%e2%80%99s-kplc/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Euthymics Bioscience, Inc.  Appoints Dr. Randall Marshall, Leader in the Psychiatric Field, as Executive Director, Medical Affairs.</title>
		<link>http://euthymics.com/press-releases/euthymics-bioscience-inc-appoints-dr-randall-marshall-leader-in-the-psychiatric-field-as-executive-director-medical-affairs/</link>
		<comments>http://euthymics.com/press-releases/euthymics-bioscience-inc-appoints-dr-randall-marshall-leader-in-the-psychiatric-field-as-executive-director-medical-affairs/#comments</comments>
		<pubDate>Wed, 09 Nov 2011 12:35:42 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Press Releases]]></category>

		<guid isPermaLink="false">http://euthymics.com/?p=376</guid>
		<description><![CDATA[Euthymics Bioscience, Inc. Appoints Dr. Randall Marshall, Leader in the Psychiatric Field, as Executive Director, &#8230; <a href="http://euthymics.com/press-releases/euthymics-bioscience-inc-appoints-dr-randall-marshall-leader-in-the-psychiatric-field-as-executive-director-medical-affairs/"> </a>]]></description>
			<content:encoded><![CDATA[<p><strong></p>
<p style="display: inline !important;">Euthymics Bioscience, Inc.  Appoints Dr. Randall Marshall, Leader in the Psychiatric Field, as Executive Director, Medical Affairs.</p>
<p></strong></p>
<p><strong><a href="http://euthymics.com/wp-content/uploads/2011/11/Euthymics_Marshall_Appointment_110811_FINAL.pdf">Euthymics_Marshall_Appointment_110811_FINAL.pdf</a><br />
</strong></p>
]]></content:encoded>
			<wfw:commentRss>http://euthymics.com/press-releases/euthymics-bioscience-inc-appoints-dr-randall-marshall-leader-in-the-psychiatric-field-as-executive-director-medical-affairs/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Dr. M. Lane Peyton, TRIADE clinical investigator, discusses the trial and Euthymics’ amitifadine on Oklahoma City’s KFOR News Channel 4</title>
		<link>http://euthymics.com/in-the-news/dr-m-lane-peyton-triade-clinical-investigator-discusses-the-trial-and-euthymics%e2%80%99-amitifadine-on-oklahoma-city%e2%80%99s-kfor-news-channel-4/</link>
		<comments>http://euthymics.com/in-the-news/dr-m-lane-peyton-triade-clinical-investigator-discusses-the-trial-and-euthymics%e2%80%99-amitifadine-on-oklahoma-city%e2%80%99s-kfor-news-channel-4/#comments</comments>
		<pubDate>Thu, 20 Oct 2011 22:02:16 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[In The News]]></category>

		<guid isPermaLink="false">http://euthymics.com/?p=411</guid>
		<description><![CDATA[October 20, 2011 &#8211;  Click here to view]]></description>
			<content:encoded><![CDATA[<p>October 20, 2011 &#8211;  <a href="http://www.kfor.com/videobeta/?watchId=b4d5284f-6fbe-456a-b816-e09368bef04f" target="_blank">Click here to view</a></p>
]]></content:encoded>
			<wfw:commentRss>http://euthymics.com/in-the-news/dr-m-lane-peyton-triade-clinical-investigator-discusses-the-trial-and-euthymics%e2%80%99-amitifadine-on-oklahoma-city%e2%80%99s-kfor-news-channel-4/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>TRIADE clinical trial investigator Dr. Eugene DuBoff discusses TRIADE and Euthymics&#8217; amitifadine on Denver, Colorado&#8217;s KMGH Channel 7.</title>
		<link>http://euthymics.com/in-the-news/september-12-2011-%e2%80%93-triade-clinical-trial-investigator-dr-eugene-duboff-discusses-triade-and-euthymics-amitifadine-on-denver-colorados-kmgh-channel-7/</link>
		<comments>http://euthymics.com/in-the-news/september-12-2011-%e2%80%93-triade-clinical-trial-investigator-dr-eugene-duboff-discusses-triade-and-euthymics-amitifadine-on-denver-colorados-kmgh-channel-7/#comments</comments>
		<pubDate>Mon, 12 Sep 2011 19:20:36 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[In The News]]></category>

		<guid isPermaLink="false">http://euthymics.com/?p=363</guid>
		<description><![CDATA[September 12, 2011 – Click here to view.]]></description>
			<content:encoded><![CDATA[<p><strong><strong>September 12, 2011 – </strong> <a title="TRIADE clinical trial investigator Dr. Eugene DuBoff discusses TRIADE and Euthymics' amitifadine on Denver, Colorado's KMGH Channel 7. " href="http://www.thedenverchannel.com/video/29159068/index.html?taf=den" target="_blank">Click here to view.</a></strong></p>
]]></content:encoded>
			<wfw:commentRss>http://euthymics.com/in-the-news/september-12-2011-%e2%80%93-triade-clinical-trial-investigator-dr-eugene-duboff-discusses-triade-and-euthymics-amitifadine-on-denver-colorados-kmgh-channel-7/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

